Cordlife launches newborn metabolic screening service in Hong Kong

Cordlife launches newborn metabolic screening service in Hong Kong

By: 
Michelle Zhu
02/05/18, 01:14 pm

SINGAPORE (May 2): HealthBaby Biotech (Hong Kong), a wholly-owned subsidiary of Cordlife Group, has launched a newborn metabolic screening service in Hong Kong.

This comes as part of Cordlife’s move to expand its diagnostics business, says the group in a press release issued on Wednesday.

Named Metascreen, the service uses urine instead of blood to detect over 100 inherited metabolic disorders – which is much more than what can be detected by conventional newborn metabolic screening tests currently available in Hong Kong, according to the group.

The specimens are taken from babies 48 hours after birth and up to six months old, and will be testing using an US-FDA-approved Gas Chromatography/Mass Spectrometry platform from Japan at the laboratory of Hong Kong Screening Centre, which is another subsidiary of Cordlife.

Aside from Metascreen being a non-invasive procedure, Cordlife emphasises that using urine as a test specimen is highly effective as metabolites tend to accumulate in urine first, while blood accumulation of toxic substances will only appear once the kidney clearance capacity is exceeded.

The group also says that Metascreen can provide “highly specific and definite results” as it analyses up to four analyte profiles to detect a single metabolic disorder – which helps to reduce false positive rates compared to conventional newborn metabolic screening, which usually only uses one or two analyte profiles in comparison.

“The launch of Metascreen by HealthBaby enables us to reach an even wider audience in Hong Kong. This will give more parents the opportunity to take proactive steps in enabling early detection, which can help avoid lifelong and potentially fatal effects of inborn errors of metabolism,” said Michael Weiss, Group CEO and Executive Director of Cordlife.

“New Cordlife is all about leveraging our extensive, multi-national platform to access large pockets of demand for all new offerings. We will continue to add innovative new services that can, to the greatest extent possible, be ‘plugged in and played’ across the entire system,” he adds.

As at 1.15pm, shares in Cordlife are trading flat at 70 cents.

DBS kept at 'buy' with still more upside expected ahead: RHB

SINGAPORE (Jan 21): RHB Research is maintaining its “buy” call on DBS Group Holdings with an unchanged target price of $29.80. This comes on the back of expectations of still more upside ahead, led by widening net interest margin (NIM). Analyst Leng Seng Choon notes that the 3-month SIBOR has been on a rising trend. It currently stands at 1.89%, after hitting an average of 1.73% in 4Q18 – some 0.1 percentage point higher than the preceding quarter. While he explains that there is some lag effect from the SIBOR rise to filter through to NIM widening, Leng believes DBS’ 4Q18 NIM....
Read More >>

Temasek ramps up pressure over Standard Chartered turnround: FT

SINGAPORE (Jan 21): Standard Chartered’s largest investor Temasek has grown frustrated with the slow pace of chief executive Bill Winters’ turnround, according to a report by The Financial Times of UK, and is stepping up pressure on the UK-listed bank ahead of his pivotal strategy update in February. The Singapore state investment company, which owns about 16% of StanChart, was reported by FT to be asking for more frequent and detailed briefings from top executives and even floated the prospect of taking a board seat in a meeting last year, two people with knowledge of the discussion to....
Read More >>

Ascendas-Singbridge properties to house public EV charging network with help from SP Group

SINGAPORE (Jan 21): Ascendas-Singbridge Group is appointed as Singapore Power (SP) Group’s first major location partner in its plans to build “Singapore’s largest and fasted public EV charging network” with 1,000 charging points island-wide by 2020. Under the partnership, 24 charging points were installed in six buildings owned by Ascendas-Singbridge – Hyflux Innovation Centre at  80 Bendemeer Road, Corporation Place, Techlink, Techplace I, The Capricorn and The Kendall – with operations commencing in phases since Dec 2018.   Main image: SP Group CEO Wong Kim Yin (l....
Read More >>